Osiris appoints manager, market access and reimbursement
This article was originally published in Scrip
Stem cell company Osiris Therapeutics has named Therésa K Dixon general manager of market access and reimbursement. She will report directly to Osiris' president and CEO Dr Lode Debrabandere. Prior to joining the Columbia, Maryland-based company, Ms Dixon was vice-president of governing affairs and health economics at Advanced BioHealing (acquired by Shire in 2011).